Browse by Industry
Filter News
Found 29,873 articles
-
Roche and privately-held cell therapy company SQZ will jointly develop oncology products based on antigen presenting cells (APCs) that are created by the SQZ platform.
-
BioSpace Movers and Shakers for Oct. 15
10/15/2018
Who mixed things up in the biotech world this past week? Pfizer announces its leadership team, Rheos gets a new COO, and board of directors updates from multiple biopharma companies. -
Berkeley Lights calls itself a digital cell biology company. It develops and markets tech platforms for what it calls “the intersection of biology, technology and information.”
-
The U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee voted to recommend AcelRx Pharmaceuticals’ Dsuvia to manage moderate-to-severe pain.
-
Depression Awareness Month: Ketamine Clinics Put Not-Always Flattering Spotlight on Treatment
10/15/2018
Depression affects almost 20 million Americans yearly and major depressive disorders affect nearly 300 million people worldwide. The annual market for these disorders is approximately $83 billion. -
NIH Awards Grant to Battle Sepsis to San Diego's Allele Biotechnology and Pharmaceuticals
10/15/2018
The National Institute of General Medical Sciences, part of the National Institutes of Health, awarded Allele Biotechnology and Pharmaceuticals a Small Business Innovative Research grant to develop therapies for sepsis. -
Harvard Medical School and Brigham and Women’s Hospital are leading the call to remove the papers from the lab of Dr. Piero Anversa, a pioneer in the field of cardiac research.
-
China’s Innovent Biologics reportedly is continuing with its plans to raise $423 million in its Hong Kong IPO. If so, it would be the biggest biotech IPO out of Hong Kong this year.
-
Study Reveals Hidden (Potentially Dangerous) Pharmaceuticals May Be Found in OTC Supplements
10/15/2018
A new study published Friday in JAMA reports that many dietary supplements consumed by people in the United States contain unapproved pharmaceutical ingredients in the over-the-counter products that pose a health risk for unsuspecting consumers. -
Chugai Presents Results from Phase III Study of Satralizumab in NMOSD at ECTRIMS 2018
10/15/2018
Satralizumab added to baseline therapy significantly reduced risk of relapse
-
FSD Pharma and SciCann Therapeutics to Attend the CannX International Medical Cannabis Convention in Tel Aviv Israel
10/15/2018
FSD Pharma Inc. is pleased to announce that its Head of Scientific Advisory Board, Dr. Zohar Koren, will attend the 3rd International Medical Cannabis Conference, ("CannX") in Tel Aviv, Israel from October 14 to 16, 2018.
-
Therap's Dashboard Analytics Tool Offers Aggregate Health Care Data Insight for Improved Health Outcomes
10/15/2018
Therap's business intelligence tool for statistical data analysis now features a health dashboard for tracking data and analyzing an individual's health status and progress.
-
Advicenne Receives Health Canada Clearance to Extend its Pivotal Phase III Trial of ADV7103 in Canada
10/15/2018
Advicenne (Paris:ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announced today that it has received a No Objection Letter to extend its ARENA-2 pivotal Phase III trial
-
Weleda North America Partners with The Foundation for Living Beauty
10/15/2018
Weleda announces a new partnership with The Foundation for Living Beauty, a nonprofit organization supporting women with cancer.
-
Nonprofit Workers Compensation, Health Insurance Providers IRMA and IPBC Seek Damages From Opioid Epidemic in First-of-its Kind Illinois Lawsuit
10/15/2018
Today, two Illinois-based nonprofit risk pools, who provide more than 203 local municipalities and other public entities with cost-effective workers’ compensation and employee healthcare insurance, filed a joint lawsuit in the Circuit Court of Cook County against leading opioid manufacturers, distributors, professional associations, and prescribers.
-
ITF Pharma Announces Availability Of TIGLUTIK™ (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) In The United States
10/15/2018
ITF Pharma, a U.S.-based specialty pharmaceutical company and a subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, announced today the U.S. availability of its first commercial product, TIGLUTIK™
-
BayCare Health Plans Launches Insurance Products
10/15/2018
BayCare Health Plans begins enrollment in its first health insurance products, two Medicare Advantage (HMO) plans called BayCarePlus.
-
Avon And American Cancer Society Team Up In The Fight Against Breast Cancer
10/15/2018
Avon is continuing its commitment to the fight against breast cancer with fundraising and awareness activations throughout October's Breast Cancer Awareness Month.
-
Medline Awards $150,000 in Breast Cancer Community Grants for Innovative Programs
10/15/2018
Medline has awarded $150,000 in its inaugural Medline Breast Cancer Awareness grants to six organizations fighting to eradicate breast cancer and providing counseling.
-
Genoox and Microsoft Healthcare partner to help advance precision medicine
10/15/2018
Genoox announced today it is partnering with Microsoft Healthcare to bring its Microsoft Genomics service to Genoox's global customers to help advance precision medicine.